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Key Findings
n The Rapid Supply Chain Modeling (RSCM) Tool
addresses a need for more rapid and flexible ways to
model the cost impact of changes to a country’s
supply chain design or context.
n We compared the RSCM Tool against existing cost
modeling tools and found it capable of producing
similar results across a wide range of countries and
supply chain designs.
n The ideal user for the RSCM Tool is a technical
officer familiar with Excel and supply chain concepts;
the outputs can inform both technical discussions
and high-level policy decisions.
Key Implications
Health system leaders and their technical
teams should consider using the RSCM Tool
to streamline the beginning stages of a supply
chain design initiative, particularly in the following
use scenarios:
n Generating estimates of high-level impact to inform
initial advocacy efforts
n Sustaining momentum from initial workshops by
quickly addressing supply chain questions
n Narrowing down a wide range of initial supply chain
design possibilities to help policy makers more
quickly focus on the highest-impact design changes
ABSTRACT
Effective and efficient health supply chains play a vital role in
achieving health outcomes by ensuring supplies are available
for people to access quality health services. However, supplying
health commodities to service delivery points is complex and cost-
ly in many low- and middle-income countries. Thus, governments
and partner organizations are often interested in understanding
how to design their health supply chains more cost efficiently.
Several modeling tools exist in the public and private market that
can help assess supply chain efficiency and identify supply chain
design improvements. These tools are generally capable of pro-
viding users with very precise cost estimates, but they often use
proprietary software and require detailed data inputs. This can
result in a somewhat lengthy and expensive analysis process,
which may be prohibitive for many decision makers, especially
in the early stages of a supply chain design process. For many
use cases, such as advocacy, informing workshop and technical
meetings, and narrowing down initial design options, decision
makers may often be willing to trade some detail and accuracy
in exchange for quicker and lower-cost analysis results. To our
knowledge, there are no publicly available tools focused on gen-
erating quick, high-level estimates of the cost and efficiency of
different supply chain designs.
To address this gap, we designed and tested an Excel-based
Rapid Supply Chain Modeling (RSCM) Tool. Our assessment indi-
cated that, despite requiring significantly less data, the RSCM
Tool can generate cost estimates that are similar to other common
analysis and modeling methods. Furthermore, to better under-
stand how the RSCM Tool aligns with real-world processes and
decision-making timelines, we used it to inform an ongoing im-
munization supply chain redesign in Angola. For the use cases
described above we believe that the RSCM Tool addresses an im-
portant need for quicker and less expensive ways to identify more
cost-efficient supply chain designs.
BACKGROUND
Supply chains are a key component of any well-functioning health system.1 For vaccines, medicines,
and other health products to be effective at preventing
and treating disease, they must be accessible to the peo-
ple who need them, when and where they are needed.
Health supply chains that can reliably deliver these pro-
ducts to the point of care are vital to ensuring access to
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quality health care and to achieving positive
health outcomes.2–4
However, in many low- and middle-income
countries (LMICs), health supply chains fail to
ensure consistent availability of critical health
products.5 According to the most recent World
Medicines Report, a typical public clinic in sub-
Saharan Africa averaged only 57% availability
of its required essential medicines, and nearly
25% of all LMIC patients were regularly unable
to access medicines needed for treatment.6 In ad-
dition, global vaccination coverage has plateaued
at 80%–85% since 2010, and supply chain ineffi-
ciencies are considered a significant driver.7,8 These
same supply chains are also expensive to operate, re-
quiring millions of dollars of annual funding to sup-
ply thousands of public health facilities throughout
a given country.9,10 For these reasons, improving
health supply chain efficiency and effectiveness is a
key objective for donor agencies, governments, and
other health care stakeholders.11–13
One important pathway to achieving this ob-
jective is restructuring and improving a supply
chain’s design (i.e., the overarching strategy for
organizing a supply chain network and its human
resources, technologies, and processes). Recent
studies have demonstrated that improving a sup-
ply chain’s design can lead to more cost-efficient
delivery and better product availability in health
facilities.14–18 Thus, donor agencies like Gavi, the
Vaccine Alliance, have explicitly incorporated
supply chain design into their supply chain strate-
gies,19 and country governments are prioritizing
supply chain redesign and strategy development
activities in their national health plans.20,21
The task of analyzing and identifying an im-
proved supply chain design can often be challeng-
ing for a couple of reasons. First, detailed supply
chain data (e.g., operating costs, product demand,
facility locations) are often unavailable or time in-
tensive to collect. Second, many existing tools
used to collect and analyze such data are intended
to provide a snapshot of the current system,22
whereas a design analysis requires flexible models
that can predict the impact of large-scale changes
to the supply chain. Although more sophisticated
supply chain modeling and optimization tools do
exist for this purpose, they typically require pro-
prietary software and specialized modeling skills
and/or consultants. In total, a supply chain review
and redesign process using these current methods
can require at least 3–6 months and US$250,000–
US$500,000, according to recent estimates.23
The detailed and precise outputs from such
tools are necessary in some circumstances,
particularly at the final stages of a supply chain de-
sign process when the focus is on fine-tuning and
implementing a specific plan. However, there are a
broad range of other instances where the required
time and cost are prohibitive. This could include
situations like conducting initial advocacy for sup-
ply chain improvements, informing workshops
andmeeting discussions in real time, or narrowing
down a wide range of improvement options in the
early stages of a supply chain design process. In
such cases, leaders from ministries of health and
partner organizationwould likely trade some level
of detail and accuracy in exchange for reducing
the time and cost of analysis. To our knowledge,
there are no publicly available modeling tools
that are flexible enough to help decision makers
evaluate the cost and efficiency of different supply
chain designs, while also minimizing the need for
data collection and specialized software skills.
In this article, we present the design and test-
ing of a Rapid Supply Chain Modeling (RSCM)
Tool aimed at addressing this gap. We describe
key attributes of the RSCM Tool, validate its
results against existing supply chain analyses, and
explore how it can help inform a country’s supply
chain redesign process.
METHODOLOGY: DESIGNING A
TOOL FOR RAPID ANALYSIS USE
CASES
The RSCM Tool is a quantitative, Excel-based
model designed to quickly estimate costs and basic
efficiency metrics for multiple supply chain design
scenarios. It requires users to input information
about the design and general characteristics of a
country’s current supply chain, including: supply
chain network information, such as land area and
number of facilities; cost parameters, such as the
cost of labor, fuel, or vehicles; and storage and dis-
tribution guidelines, such as inventory levels or
frequency of delivery.
Using these inputs, the RSCM Tool models key
operational supply chain activities and calculates
several resulting output metrics, including: annu-
al operating cost, disaggregated by tier and supply
chain function (i.e., storage, transportation, and
management); expected utilization of resources
like vehicle and warehouse capacity; and opera-
tional statistics like kilometers traveled or volume
delivered per facility.
Within the tool, those inputs and outputs
worksheets can be replicated to create multiple
supply chain scenarios, which can be compared
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To address the identified need for quicker and
more cost-effective decision-making tools, we
made several design decisions that help the RSCM
Tool maintain flexibility, quick setup time, and
minimal data collection needs (Table 1).
Simplifying Modeling Assumptions
Like most modeling tools, the RSCM Tool uses
assumptions to strike a desired balance between
simplicity and accuracy. Since our goal is to provide
faster results by reducing overall data requirements,
we ask the user to define a typical facility at each
supply chain tier, rather than requiring detailed de-
mand, location, and cost data for every facility.
While the results do not provide detailed out-
puts for individual facilities, we hypothesize that
for high-level, system-wide design analyses, the
RSCM Tool’s outputs will be reasonably similar to
those of other common supply chain modeling
tools. We test this hypothesis and quantify the ef-
fect of the tool’s assumptions in the validation sec-
tion below.
Standardized “Menu” of Design Levers
Most global health supply chains can be broken
down into a relatively small set of “building block”
design decisions in key functional areas like stor-
age, transportation, and management. By incor-
porating these design levers along with common
pre-set choices/values, a user can easily create
and toggle between different distribution strate-
gies for their supply chain network.
Proxy Data andWorksheets to Address Data
Gaps
Since supply chain and cost data are often scarce,
we incorporated several supporting worksheets
and proxy datasets to help users quickly estimate
TABLE 1. Key Modeling Tool Design Decisions for Facilitating Rapid Supply Chain Analyses
Simplifying modeling assumptions: Reducing data
requirements and enable real-time calculation
Assumptions:
 All facilities at a given tier have the same demand quantity
per order period
 Demand is the same for every order period and does not
vary over time
 Facilities within a tier are evenly distributed throughout a
given region and, thus, are the same average distance to
their nearest re-supply point
Standardizing design levers: Providing flexibility
to model diverse global health distribution
strategies
 Storage: At which levels do you hold and manage
inventory? How much safety stock does each level hold,
and how frequently is it replenished?
 Transportation: What types of vehicles are used to transport
replenishment shipments? What type of distribution model is
followed at each level (e.g., hub and spoke or multi-stop
distribution loops), and are there any travel constraints
(e.g., administrative boundaries)?
 Management: Who is responsible for performing key
ordering, transport, and storage functions? What types of
technology supports people at each level?
Proxying data and worksheets to fill gaps:
Enabling quick estimation of missing data points
Supporting worksheets and datasets:
 A model for estimating immunization and/or reproductive
health demand volumes and product value, by combining
available demand planning methodologies with publicly
available demographic and product data
 A general model for converting the number of units of a
health product into a cubic-meter volume using historical
product unit volume data
 Common commercial heuristics for estimating storage
capacity of a warehouse based on its overall dimensions
 A database of typical costs for assets like vehicles,
warehousing space, and cold chain equipment
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values for common data gaps, minimizing time re-
quired for data collection.24–29 Additionally, we
compiled a set of complete input data templates,
which are proxy data from existing cost analyses
that are formatted to match the RSCM Tool’s
structure. Instead of entering each input value in-
dividually, a user can “load” a preset template as a
starting point for analysis, selectively overriding
the proxy dataset where better data exists.
Excel-Based Platform
Finally, we developed the RSCM tool in Microsoft
Excel because it is the most widespread software
that can meet the tool’s technical requirements
and run easily on most computers. Government
staff and implementing partners are often familiar
with and comfortable using Excel in their daily
work, such as for demand planning. For users
who already have Excel, there is no additional
cost to accessing the RSCM Tool. Additionally,
the tool is functional offline, which is essential for
areas with unreliable internet connectivity. This
enables the tool to be easily and widely accessible
to multiple stakeholders throughout a country,
which would be less likely if it required proprie-
tary software or license fees.
VALIDATING THE RSCM TOOL’S
METHODOLOGY
To test the validity of the methodology and
assumptions described, we conducted an assess-
ment to determinewhether the outputs generated
by the RSCM Tool were consistent with other
established methods for measuring or estimating
the costs of different supply chain designs.
Validation Approach
Our general approach was to compile detailed
datasets from recent supply chain costing and
modeling analyses and replicate each analysis us-
ing the RSCM Tool. First, we built complete sets
of data inputs for the RSCM Tool, compiling them
from a variety of sources and vetting assumptions
externally wherever possible. (The Discussion
details the main challenges we faced in building
these input datasets and how we addressed
them.) Then, we compared the RSCM Tool’s cost
estimates to the results of the original analyses.
With identical data inputs, we would expect
any discrepancy in results to be driven by differ-
ences in the modeling approach and assumptions.
For each comparison, we treated the existing anal-
ysis as a “reference” value and measured the
RSCMTool’s deviation from that value as an abso-
lute percent error.
We performed this calculation at 3 levels of
cost aggregation: (1) individual cost line items
(e.g., fuel costs for transportation at health facili-
ties); (2) total cost for each supply chain tier and
cost category; and (3) total annual cost for the en-
tire system. For each level of aggregation, we aver-
aged individual error calculations together to
obtain a mean absolute percent error (MAPE). A
lowerMAPE value implies a smaller difference be-
tween the reference and RSCM tool results.
Wewere able to obtain reference datasets from
6 recent cost and modeling analyses, covering
7 supply chain design scenarios (Table 2). We
chose these reference analyses in part based on
our ability to access underlying data since replicat-
ing the analyses as closely as possible required a
more detailed breakdown of inputs and results
(e.g., worker salary assumptions, specific vehicle
types) than what is typically available in public
reports. Additionally, we sought out analyses that
were produced and vetted by country govern-
ments and partners and actually used to inform
key stakeholder decisions. Even though these
analyses also represent estimates of true supply
chain costs, they are the best-established estimates
available, and thus, serve as ideal reference values
when validating the RSCM Tool.
Collectively, these analyses encompass a di-
verse set of current public health supply chains.
They incorporate several health program areas
and span a range of geographies across Africa and
Latin America. They also cover several common
supply chain designs, including ad hoc facility
collection, “level-skipping” or “direct delivery”
designs that bypass an administrative tier and a
“mobile warehouse” design where facility inven-
tory is periodically topped-up by visiting resupply
vehicles.30
Adjusting Data to Ensure Equivalent
Comparisons
These 6 reference analyses were conducted by dif-
ferent organizations for different purposes; hence,
they differ in methodological details like the scope
of costs included, how costs are classified, and
analysis method (e.g., simulation modeling vs. di-
rect cost measurement at a sample of facilities).
None of these methods is inherently better than
another; each uses a set of data and assumptions
that are tailored to its own unique context.
However, due to these differences, we often need-
ed to transform certain data inputs and outputs to
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ensure an equivalent comparison with the RSCM
Tool.
Many of the input parameters required by the
RSCM Tool lacked a directly comparable value in
the reference analyses, requiring us to make sev-
eral types of estimates and adjustments, including:
 Aligning Level ofDetail:ManyRSCM inputs
were available in the reference datasets but
were scoped or grouped differently. For example,
the RSCM Tool handles vehicle costs like fuel,
maintenance, and insurance individually, but
some datasets use only an aggregate “total oper-
ating cost” rate, requiring us to estimate the
breakdown of that rate into its subcomponents.
 Inferring Input Values From Results:With
some datasets (especially ones that only had
results available), we lacked explicit assump-
tions for required inputs like vehicle mainte-
nance cost rates. However, in many cases, we
were able to infer a value from data contained
in the results, such as overallmaintenance costs
and distances traveled. While we would ordi-
narily avoid using the detailed reference data-
sets as sources for RSCM Tool inputs, we were
comfortable doing so in situations where the
input parameter: (1) was an objective, numeric
value, and; (2)would likely be found elsewhere
in ministry or partner financial records that
would be accessible in a country-level applica-
tion of the tool.
 IdentifyingProxies forMissingData Inputs:
Some RSCM inputs simply were not available
in a reference dataset, often because of a differ-
ence in methodology. For example, the RSCM
Tool uses a road network circuity factor to help
estimate distances between facilities. We often
had to use Google Maps to develop a rough
proxy for this parameter because many of the
reference analyses measured actual distances
between sample facilities.
Similarly, when comparing final outputs, in
the following examples, we often had to adjust
for differences among the reference analyses in
how specific cost line items were calculated. For
example:
 Costing Unutilized Assets: Some reference
analyses and the RSCM Tool track all assets
that are owned by a supply chain (e.g., vehicles
or storage space), while other analyses track
only the fraction of those assets that are actively
used. Both approaches are valid but result in
different answers unless the assets are fully uti-
lized. Thus, when comparing against this alter-
nate approach, we scaled down the quantity of
vehicles and storage in the RSCM Tool to elimi-
nate any expected idle capacity.
 Assigning “Ownership” of Costs: The RSCM
Tool assigns the cost of a supply chain activity to
the location where that activity occurred.
Certain analyses, however, assign costs to
TABLE 2. Reference Datasets From Cost and Modeling Analyses Used to Validate the Rapid Supply Chain
Modeling Tool
Study Location Description
Bolivia and Guatemala, 2018 Three supply chain costing studies led by ForoLAC (Foro Latinoamericano y del
Caribe para el Aseguramiento de Insumos de Salud Reproductiva) that included all
major health commodities, including vaccines:
 Tarija Department, Bolivia
 Quiché Department, Guatemala
 Alta Verapaz Department, Guatemala
Mozambique, 2015 Modeling analysis conducted by VillageReach for the national and provincial
ministries of health, using the HERMES software platform (Highly Extensible Resource
for Modeling Event-Driven Supply Chains) to assess 2 immunization supply chain
design options for Manica Province in Mozambique (the baseline 4-tier design, and
a direct delivery design that skipped 1 of the tiers).
Senegal, 2017 Modeling analysis in Senegal estimating the nationwide costs of operating the
Informed Push Model strategy for delivering family planning and maternal-child
health products.
Zimbabwe, 2015 Evaluation of the Zimbabwe Assisted Pull System strategy in Manicaland Province in
Zimbabwe, which integrated commodity distribution for most health program areas
(except vaccines).
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wherever the budget line for those costs is locat-
ed. Those are not always the same locations (e.
g., if health facility vehicle maintenance is
funded out of a district budget).
 Scoping Specific Cost Categories:Reference
analyses differed in the scope of costs that they
were willing to consider. For example, several
analyses omitted depreciation costs for health
facility storage space, since the buildings are of-
ten owned by the government and require no
rent or mortgage payment. Others chose to in-
clude a nominal storage space cost, since even-
tually that health facility building would need
to be replaced.
Validation Results
Figure 1 shows the difference,measured inMAPE,
between the RSCMTool’s cost estimates and those
of the 7 reference supply chain scenarios. MAPE
values were lowest when comparing total supply
chain operating costs between the RSCM esti-
mates and the reference analyses. At this level,
the only comparison to exceed a 4% MAPE value
was theMozambique baseline (6.7%). This implies
that the modeling assumptions and simplifications
described above generally have the smallest impact
on high-level cost estimates. As the comparisons
became more granular (e.g., comparing costs for
an individual tier or cost line item), the differences
became somewhat more pronounced.
We also saw a wide range of MAPE values
across the different reference analyses. Some,
such as the 2 Mozambique scenarios, saw rela-
tively high MAPE values across all 3 levels of
comparison. Others, such as Zimbabwe and the
ForoLAC (Foro Latinoamericano y del Caribe
para el Aseguramiento de Insumos de Salud
Reproductiva) studies, were relatively low across
the board. These differences appear to roughly
correlate with the level of detail available in the
underlying reference datasets. We discuss further
implications of these results in the Discussion
section.
TESTING THE TOOL IN AN
IMMUNIZATION SUPPLY CHAIN
CONTEXT
We also wanted to test the usability of the tool to
understand how it aligned with real-world pro-
cesses and timelines for conducting supply chain
design analyses. In January 2019, United Nations
Children’s Fund (UNICEF), with the support of
technical partners, worked with Angola’s Expanded
Program on Immunization (EPI) to explore a review
and redesign of its immunization supply chain (iSC).
This engagement provided us with an opportunity
to evaluate whether the RSCM Tool could be used
quickly and easily to produce high-level estimates
during a real-time supply chain redesign.
FIGURE 1. Comparison of Cost Estimates Between the Rapid Supply Chain Modeling Tool and Existing
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Abbreviation: MAPE, mean absolute percent error.
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Angola Immunization Supply Chain Context
Angola’s immunization supply chain consists of
4 tiers (national, province, municipality, and
health facility) that align with the Ministry of
Health’s administrative structure. Vaccines travel
through national, provincial, and municipality
stores on their way to 1,321 health facilities. By
conducting a supply chain design review, UNICEF
and EPI aimed to improve the efficiency of this iSC
structure and understand how those improvements
would impact deployment of resources like
vehicles and cold chain equipment. UNICEF’s
System Design Approach (Figure 2) provided an
overarching framework for this design review
process.31
We incorporated the RSCM Tool into the data
collection, validation, and modeling stage of this
process after an initial stakeholder workshop in
May 2019 and conducted a preliminary modeling
analysis while awaiting development of a more
detailed optimization model. By providing quick
interim results, our goals were to sustain stake-
holder interest and momentum post-workshop,
get government buy-in for the scenarios defined
at the workshop, and streamline subsequent
modeling analyses to focus on the most promising
areas of improvement.
Analysis of 4 Design Scenarios Using the
RSCM Tool
We used the RSCM Tool to analyze the following
4 supply chain design scenarios that EPI represen-
tatives and partners identified at the initial stake-
holder workshop.
1. A baseline scenario represented the current-
state supply chain design, including the 4-tier
structure, transportation strategy, andmonthly
resupply frequency.
2. An “ideal baseline” scenario, which main-
tained the current supply chain design but in-
creased cold storage capacity to account for
current shortages, represented the “true” cost
to run the current design with added cold
storage.
3. A reduced resupply frequency scenario low-
ered transport costs by switching frommonthly
to 2-month resupply cycles at the municipality
level.
4. A level-skipping scenario bypassed the province
level, with the national warehouse delivering
supplies monthly to municipalities, resulting in
a 3-tiered distribution structure.
The process for collecting data and analyzing
these scenarios involved several key steps: (1) inter-
viewing national-level EPI officials about key supply
chain policies, (2) compiling and entering available
data into an RSCM Tool data template, (3) identify-
ing proxy data sources to fill any remaining data
gaps, and (4) identifying how to model each design
scenario in the RSCM Tool. In total, this process re-
quired approximately 3 weeks’ worth of personnel
time, divided across 3 people. However, that time re-
quirement could have been reduced significantly
(30%–50% in our estimation) in a scenario where
everyone working on the analysis was located to-
gether in Angola and fluent in Portuguese, the offi-
cial language in Angola.
RSCMModeling Results
Total cost estimates from our analysis of these sce-
narios are shown in Figure 3.
For the analysis, we referenced the “ideal base-
line” as 100% as it represents the “true” cost of
running the supply chain; this reflects the added
cost Angola would need to invest in the system re-
gardless of any design changes. Based on the
results, the level-skipping approach appears to be
FIGURE 2. United Nation’s Children’s Fund System Design Approach Used to Review Angola’s Expanded
Program on Immunization Supply Chain
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themost cost-efficient option, reducing annual costs
by 7% over the current baseline and 11% over the
ideal baseline. This difference translates to potential
savings of several hundred thousand US dollars
per year. Apart from the obvious reduction in
storage costs, bypassing the provincial level also
lowered overall transport costs by enabling more
efficient transportation routes from national lev-
el to municipalities.
We presented these initial results to stake-
holders from UNICEF’s Supply Division and the
Angola country office in August 2019, and they
will be using the results to get government buy-in
for subsequent in-depth modeling. Testing the
RSCM in Angola provided an opportunity to as-
sess the RSCM Tool’s ability to quickly estimate
results for stakeholders and provide guidance on
which options are worth exploring in more depth.
DISCUSSION
We tested the RSCMTool in 2ways: (1) by validat-
ing it against existing supply chain costing analy-
ses, and (2) by using it to help inform an ongoing
supply chain design review in Angola. We discuss
the outcomes of those testing processes and what
they mean for the usability and limitations of the
RSCM Tool.
Interpretation of the Validation Results
The validation comparisons shown in Figure 1
generally align with our expectations of what a
high-level, rapid tool should be able to achieve.
The RSCM Tool was very good at replicating total
operating cost numbers from the reference analy-
ses. Even at the tier- and category-specific level,
estimates were often within65% of the reference
analysis results.
It is not surprising that the RSCM Tool and the
reference analyses differ somewhat in their results,
given the differences in their underlying modeling
assumptions. For example, we assume identical de-
mand and travel distances for all facilities within a
given tier, but there is often variation among real-
world facilities (e.g., large, accessible urban health
facilities vs. small, remote rural health facilities).
Those differences tend to average out over a large
sample of facilities, but even at a national level,
this assumption likely contributes to the MAPE
values in Figure 1. The data adjustments we de-
scribed in the Methodology section also likely con-
tribute to these differences.
Our key question, then, is determining what
constitutes an acceptable MAPE level for the com-
parisons shown in Figure 1. This is challenging be-
cause the definition of “acceptable” varies with the
urgency and importance of the use case. Users
who need answers very quickly or cheaply are
likely to accept larger discrepancies than those
who have more resources or a larger decision at
stake. For this question, the literature on forecast-
ing accuracy (where MAPE is an important metric)
may provide the best guidance regarding what is
generally considered acceptable. Landscape reviews
of published forecasts provide numerous examples
of both public and private organizations willing
FIGURE 3. Change in Total Annual Operating Cost Estimates by Design Scenario for Angola’s Immunization
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to make strategic decisions with error rates of
10%–20% or more.32–34 Thus, we assume that sim-
ilar rates for the validation study (<10% MAPE at
the total cost level, and <20%MAPE for individual
line items), would be generally acceptable given the
“rapid”use caseswe are targeting.Wepresented this
proposed threshold at several global health stake-
holder consultations, workshops, and conferences,
and received general approval fromparticipants.35,36
However, as we suggest earlier, the user must ulti-
mately define what level of accuracy is warranted.
Furthermore, like the RSCM Tool, the refer-
ence analyses fromour validation are also estimates
of true supply chain costs, based on othermodeling
tools and data analyses. Thus, they are also subject
to similar accuracy challenges, including sample
and observation bias, unreliable informants, and
assumptions about scaling and interpreting data.
We used these existing analyses as reference values
because they represent the best data currently
available, but they are likely not a perfect represen-
tation of true supply chain costs, and the MAPE
values shown in Figure 1 should be interpreted
with that in mind. Rather than being a true “accu-
racy” measure, the MAPE values represent evi-
dence that, given similar inputs, the RSCM Tool
can generate supply chain cost estimates that are
comparable to other establishedmethods.
Lessons From an Immunization Supply Chain
Design Context
Although Angola’s iSC system redesign is still in
process, the RSCM Tool was able to generate help-
ful information for stakeholders:
 Overall estimated operating cost of the current
supply chain
 The roughmagnitude of cost savings that could
result from implementing an improved iSC
design
 The estimated cost of addressing current cold
chain equipment shortages
 Evidence for the types of improvements (i.e.,
level skipping) that will likely have the largest
financial impact
Having these data points early in the design pro-
cess can help the EPI better prioritize the effort it puts
into iSC design improvements (and compare against
other supply chain or health system improvements).
It can also inform specific requests for subsequent
deep-dive analyses, such as identifying optimal
modes of transport for a level-skipping solution or
fine-tuning the regions where this solution should
apply.
The RSCM Tool generally fared well with the
data and modeling challenges we encountered
during this analysis in Angola. Data visibility was
an issue at municipality and health facility levels,
but national-level government staff were able to
describe the “typical” municipality and health fa-
cility easily. We were able to use proxy data and
supporting worksheets to estimate other missing
values (e.g., typical demand per facility, govern-
ment salary rates, and average distances between
storage facilities at each tier). We also developed
an estimation method to capture the effect of sup-
plemental immunization activities, which occur in
Angola every 6 months and create a temporary
30% increase in throughput during thosemonths.
The RSCM Tool does not inherently consider
month-to-month differences in demand volume,
but we were able to use the tool’s storage/trans-
port utilization estimates to add buffer capacity to
handle those temporary demand spikes. In these
ways, we were able to address substantial data vis-
ibility and modeling challenges and produce
results in a relatively quick timeframe.
Most importantly, the process of working with
external stakeholders to conduct this analysis
helped clarify 2 key lessons for enabling long-
term external use of the RSCM Tool.
1. Users Must Be FamiliarWith Data Analysis and
Supply Chain Concepts
The tool, while designed for ease of use, is not a
substitute for data analysis and supply chain
knowledge. We have included various features to
maximize usability of the tool (e.g., user guides,
detailed interpretation notes, formatting to high-
light errors and omissions), but we cannot predict
all the possible analysis situations and challenges
that future users might encounter. The user must
be capable of making informed judgments about
how to utilize imperfect data sources and align
them with the RSCM tool’s structure, and how to
handle novel modeling situations. Thus, a techni-
cal or logistics officer or someone familiar with
assessing supply chain operating costs is likely to
be the ideal long-term user of the RSCM Tool
within a government or partner organization.
2. Adopting the Tool May Require Sustained
Engagement
Transferring long-termuse of the RSCMTool to an
external organization may still require sustained
engagement, at least while the tool is relatively
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new and unknown. Our Angola analysis suc-
ceeded in generating interest in the tool, but it
was a proof-of-concept for many stakeholders.
They needed to see that initial analysis conducted
before they would consider using the tool them-
selves the next time around. Thus, while we
designed the tool so that anyone with Excel can
download it and understand how to use it, we rec-
ognize that in many cases effective dissemination
will involve direct engagement with country and
partner stakeholders over the course of multiple
use cases and analyses.
Limitations of the RSCM Tool Methodology
Although the RSCM Tool can cover a wide range
of supply chain designs and contexts, in the fol-
lowing situations, the tool’s structure and assump-
tions are likely to create bias or error in the results.
In some supply chains a single “typical” facility
may be difficult to define. This can occur for regions
with unusual geographies, or with facilities highly
concentrated in 1 area. It could also include supply
chains with extremely variable demand over time
or across facilities. These supply chains likely re-
quire more detailed data to model in the RSCM
Tool, since built-in worksheets and proxy data
may be less representative, and assumptions may
change significantly between different scenarios.
Some supply chains utilize different strategies
for different subregions or program areas. If supply
chain designs are not consistent across products or
facilities (e.g., a region that uses a different distribu-
tion strategy than the rest of the country), the
RSCM Tool requires the user to create separate
models for each design and then aggregate the
results.
For small supply chain networks, a single out-
lier facility can greatly influence results. While the
RSCM Tool can model very small regions (e.g., a
district with 20 health facilities), there is a much
greater risk that a single outlier facility could
skew the results. Those outliers will tend to average
out over a large enough sample, so our analyses
thus far have typically modeled at least an entire
province/region (generally more than 100 health
facilities).
These limitations are an important consider-
ation when deciding whether to use the RSCM
Tool for a given analysis. If addressing the limita-
tion is serious enough that it requires a large quan-
tity of individual health facility data to resolve, then
users should also consider other modeling tools that
can utilize detailed facility-level data. However, if
the limitation can be addressed with a relatively
small fix (e.g., manually adjusting a few parameters
or creating a few scenarios), then the RSCM Tool
may still be suitable.
Broadening Access to Supply Chain Design
Analysis
Given the RSCM Tool’s characteristics and limita-
tions, we can envision it being useful in a wide
range of situations where health system leaders
need quick, high-level supply chain cost and
design insights but lack the resources or time
for a comprehensive data collection and in-
depth modeling analysis.
Advocating for Supply Chain Initiatives
Building initial political support for supply chain
improvements often requires advocates to dem-
onstrate the potential cost and impact of those
improvements but until that support exists, resources
are often unavailable to conduct in-depth and costly
analysis. Being able to quickly generate high-level,
country-specific data can help advocates more effec-
tively build initial political support.
Prioritizing Health Investment Decisions
Health system leaders must allocate funding
across numerous initiatives to maximize health
impact but cannot intensively analyze all potential
options. High-level supply chain cost data can help
leaders better compare supply chain improve-
ments with other health investments.
Streamlining Traditional Supply Chain Redesign
Processes
As our engagement in Angola demonstrated, the
RSCM Tool can serve as a preliminary filter for
more in-depthmodeling analysis, quickly narrow-
ing down a wide range of initial design possibili-
ties. In this way the RSCM Tool can enable a
more targeted use of complex, expensive model-
ing software by allowing to tools to focus only on
the options with the most potential. Sequencing
both tools in this fashion can facilitate a quicker
and lower-cost supply chain redesign process that
still yields sufficient detail where needed (e.g., for
final budgeting and implementation planning).
Informing Real-TimeWorkshop/Meeting
Discussions
When starting from a pre-existing data template,
the RSCM Tool can generate scenario analyses in
a matter of minutes or hours. This opens the possi-
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everyday government/donor meetings or addres-
sing workshop questions in real-time.
Tailoring Funding Allocations
Many donor and government organizations allo-
cate supply chain funding as a percentage of com-
modity value,22 which is a quickmethod but often
uncorrelated with logistics costs. The RSCM Tool
can provide quick estimates based on a more pre-
dictive attribute (volume) and tailored to a specific
country context.
Validating Logistics Company Bids
Outsourcing supply chain activities is another sit-
uationwhere cost information is valuable but does
not warrant its own extensive study. Having a
readily available approximation of supply chain
costs can help donors and governments more ef-
fectively negotiate with private logistics compa-
nies when they are bidding for services.
The use scenarios described in this article are
not well-served by the existing landscape of sup-
ply chain tools, as they are typically diffuse,
short-lived, and often too small or early stage to
warrant a significant resource investment for
analysis on their own. However, they are still im-
portant in building towards and sustaining supply
chain outcomes. By providing stakeholders with
rapid, data-driven insights in these types of diffuse
situations, we can better initiate and sustain policy
discussions about supply chain, more efficiently
build consensus around the right types of solutions,
and more effectively generate political will for
larger-scale supply chain analyses and initiatives.
CONCLUSION
Identifying, costing, analyzing supply chain design
improvements has traditionally been a highly
time- and resource-intensive process. The RSCM
Tool reduces these barriers, foregoing some degree
of detail and accuracy to minimize data collection
and enable quick turnaround of results. We tested
and validated the RSCM Tool and found it capable
of replicating high-level results of more traditional
costing and modeling approaches. It also adapted
well to existing country-level supply chain rede-
sign processes, helping generate quick preliminary
results that guidemore in-depthmodeling and de-
cision making. We believe the RSCM Tool can
help health system leaders make more timely and
informed supply chain decisions, helping ensure
efficient and reliable access to health products
that are critical to improving health outcomes.
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